Search Results  for '4745.TWO'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cowealth Medical Holding Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cowealth Medical Holding Co Ltd (4745-OT)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Aug 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Cowealth Medical Holding Co Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Aug 2015 Wright Reports 55 $75.00

Cowealth (4745 TT): 2Q15 EPS Missed Expectation

Although we believe that examination/treatment equipment for dry eye syndrome could make stable contributions to consumables ...

10 Aug 2015 MasterLink Securities Corporation 6 $58.00

Cowealth (4745 TT, NT$57.5, OP, TP: NT$84): 2Q15 earnings miss; arbitration award to boost 2016F net profit

Event 2Q15 EPS was NT$0.74, missing our forecast and consensus due to higher-than-expected marketing and arbitration-related...

05 Aug 2015 KGI Greater China 6 $58.00

合富 (4745 TT, NT$57.5, 增加持股, 目標價 NT$84): 2Q15獲利低於預期,仲裁和解金可望推升2016年獲利

重要訊息 合富自結2Q15每股盈餘0.74元,低於凱基與共識,主因為高於預期的產品前期行銷費用及認列仲裁相關費用。我們對合富2016年營運看法依舊正向,且預期與Accuray仲裁和解金可望大幅挹注2016年淨利,重申「增加持股」。 評論及分析...

05 Aug 2015 KGI Greater China 6 $46.00

F-合富(4745) :2Q EPS低於預期,2015年獲利轉為衰退

雖然我們認為乾眼症檢查/治療設備長期而言可以貢獻穩定的耗材收入,但乾眼症屬新產品需時間打入醫院體系,且在政策與法規的因素下,2015年乾眼症設備難以放量,然而,2015年需先投入推廣費用,且合富主力產品層峰計畫新合約的毛利率有下滑疑慮,合富2015年...

04 Aug 2015 MasterLink Securities Corporation 5 $35.00

Cowealth (4745 TT, NT$85.7, OP): 1Q15 results beat, growth to take off from 2H15

Event Preliminary 1Q15 EPS was NT$1.66, beating our estimate and consensus by a respective 22% and 11% on better-than-expect...

11 May 2015 KGI Greater China 6 $58.00

COWEALTH MEDICAL HOLDING CO LTD: Downgraded to Average

17 Mar 2015 Sadif Analytics Prime 3 $10.00

合富 (4745 TT, NT$94.5, 增加持股): 4Q14優於市場預期,15年前景亮麗

重要訊息 4Q14自結每股盈餘1.63元,與我們預估1.65元相當,並優於市場共識的1.47元達11%。基於預估2014-2016年營收及淨利年複合平均成長率達為29%及27%,我們對股價表現維持樂觀看法。 評論及分析 4Q14獲利優於市場...

03 Feb 2015 KGI Greater China 5 $35.00